EP3658527 - ACRYLIC ACID ANALOGS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.02.2022 Database last updated on 28.06.2024 | |
Former | Request for examination was made Status updated on 01.05.2020 | ||
Former | The international publication has been made Status updated on 02.02.2019 | Most recent event Tooltip | 18.02.2022 | Application deemed to be withdrawn | published on 23.03.2022 [2022/12] | Applicant(s) | For all designated states Recurium IP Holdings, LLC 10835 Road to the Cure, Suite 205 San Diego, CA 92121 / US | [2020/23] | Inventor(s) | 01 /
HUANG, Peter, Qinhua 10835 Road To The Cure Suite 205 San Diego CA 92121 / US | 02 /
SLEE, Deborah, Helen 10835 Road To The Cure Suite 205 San Diego CA 92121 / US | 03 /
BUNKER, Kevin, Duane 10835 Road ToThe Cure Suite 205 San Diego CA 92121 / US | 04 /
HEGDE, Sayee, Gajanan 10835 Road To The Cure Suite 205 San Diego CA 92121 / US | 05 /
HOPKINS, Chad, Daniel 10835 Road To The Cure Suite 205 San Diego CA 92121 / US | [2020/23] | Representative(s) | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | [2020/23] | Application number, filing date | 18837613.1 | 26.07.2018 | [2020/23] | WO2018US43935 | Priority number, date | US201762538486P | 28.07.2017 Original published format: US 201762538486 P | [2020/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019023481 | Date: | 31.01.2019 | Language: | EN | [2019/05] | Type: | A1 Application with search report | No.: | EP3658527 | Date: | 03.06.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.01.2019 takes the place of the publication of the European patent application. | [2020/23] | Search report(s) | International search report - published on: | AU | 31.01.2019 | (Supplementary) European search report - dispatched on: | EP | 11.03.2021 | Classification | IPC: | C07C59/56, C07C255/57, A61K31/192, A61P35/00, A61P5/32 | [2020/23] | CPC: |
C07C255/57 (EP,AU,US);
C07C59/56 (EP,AU,US);
A61P35/00 (EP,AU,US);
A61P5/32 (EP);
C07C2602/02 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/23] | Title | German: | ACRYLSÄURE-ANALOGA | [2020/23] | English: | ACRYLIC ACID ANALOGS | [2020/23] | French: | ANALOGUES DE L'ACIDE ACRYLIQUE | [2020/23] | Entry into regional phase | 10.02.2020 | National basic fee paid | 10.02.2020 | Search fee paid | 10.02.2020 | Designation fee(s) paid | 10.02.2020 | Examination fee paid | Examination procedure | 10.02.2020 | Examination requested [2020/23] | 03.09.2020 | Amendment by applicant (claims and/or description) | 12.10.2021 | Application deemed to be withdrawn, date of legal effect [2022/12] | 03.11.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/12] | Fees paid | Renewal fee | 14.07.2020 | Renewal fee patent year 03 | 15.07.2021 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2010107475 (UNIV NEW YORK STATE RES FOUND [US], et al) [I] 1-14 * page 105; compound SS1020 * * page 8, line 1 - page 9, line 27 * | International search | [X]WO9908682 (UNIV DUKE [US]) [X] 1, 2, 11-14, 16, 30, 31, 34- 36, 41-46, 62-66 & 68 * abstract; page 12, 3rd paragraph; table 1, GW 5638 and GW 7604; and claims 1, 2 and 7 *; | [A]WO03016270 (BRISTOL MYERS SQUIBB PHARMA CO [US]) [A] 1-68 * abstract; and claim 1 * | [X] - LAI, A. et al., "Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts", Journal of Medicinal Chemistry, (20150000), vol. 58, pages 4888 - 4904, XP055319324 [X] 1-14, 16-28, 30-46, 49-66 & 68 * abstract; page 4889, figure 1, compounds 4 and 5, and left column, first paragraph; page 4892, table 2, compounds 5a-c; page 4893, table 3; page 4894, table 4, compounds 10a and 10b; table 5, compounds lla-g and llj-111; and page 4898, conclusion * DOI: http://dx.doi.org/10.1021/acs.jmedchem.5b00054 |